Thrombosis in Chronic Kidney Disease in Children
Abstract
:1. Introduction
2. Epidemiology
3. VTE and Nephrotic Syndrome
4. VTE and ESRD
5. VTE and Kidney Transplantation
6. Conclusions
Author Contributions
Funding
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Wells, P.S.; Anderson, D.R.; Rodger, M.; Ginsberg, J.S.; Kearon, C.; Gent, M.; Turpie, A.G.; Bormanis, J.; Weitz, J.; Chamberlain, M.; et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: Increasing the models utility with the SimpliRED D-dimer. Thromb. Haemost. 2000, 83, 416–420. [Google Scholar] [PubMed]
- Le Gal, G.; Righini, M.; Roy, P.-M.; Sanchez, O.; Aujesky, D.; Bounameaux, H.; Perrier, A. Prediction of pulmonary embolism in the emergency department: The revised Geneva score. Ann. Intern. Med. 2006, 144, 165–171.e213. [Google Scholar] [CrossRef]
- Hennelly, K.E.; Baskin, M.N.; Monuteuax, M.C.; Hudgins, J.; Kua, E.; Commeree, A.; Kimia, R.; Lee, E.Y.; Kimia, A.; Neuman, M.I. Detection of pulmonary embolism in high-risk children. J. Pediatr. 2016, 178, 214–218. [Google Scholar] [CrossRef] [PubMed]
- Biss, T.T.; Brandao, L.R.; Kahr, W.H.A.; Chan, A.K.C.; Williams, S. Clinical probability score and D-dimer estimation lack utility in the diagnosis of childhood pulmonary embolism. J. Thromb. Haemost. 2009, 7, 1633–1638. [Google Scholar] [CrossRef] [PubMed]
- Liederman, Z.; Chan, N.; Bhagirath, V. Current Challenges in Diagnosis of Venous Thromboembolism. J. Clin. Med. 2020, 9, 3509. [Google Scholar] [CrossRef] [PubMed]
- Radulescu, V. Management of venous thrombosis in the pediatric patient. Pediatr. Health Med. Ther. 2015, 6, 111–119. [Google Scholar] [CrossRef] [Green Version]
- Nair, A.B.; Parker, R.I. Hemostatic Testing in Critically Ill Infants and Children. Front. Pediatr. 2021, 8, 606643. [Google Scholar] [CrossRef]
- Halton, J.; Brandão, L.R.; Luciani, M.; Bomgaars, L.; Chalmers, E.; Mitchell, L.G.; Nurmeev, I.; Sharathkumar, A.; Svirin, P.; Gorbatikov, K.; et al. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): A randomised, controlled, open-label, phase 2b/3, non-inferiority trial. Lancet Haematol. 2021, 8, e22–e33. [Google Scholar] [CrossRef]
- Male, C.; Lensing, A.W.A.; Palumbo, J.S.; Kumar, R.; Nurmeev, I.; Hege, K.; Bonnet, D.; Connor, P.; Hooimeijer, H.L.; Torres, M.; et al. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: A randomised, controlled, phase 3 trial. Lancet Haematol. 2020, 7, e18–e27. [Google Scholar] [CrossRef]
- Kerlin, B.A. Current and future management of pediatric venous thromboembolism. Am. J. Hematol. 2012, 87 (Suppl. 1), S68–S74. [Google Scholar] [CrossRef]
- Van Ommen, C.H.; Heijboer, H.; Büller, H.R.; Hirasing, R.A.; Heijmans, H.S.; Peters, M. Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J. Pediatr. 2001, 139, 676–681. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Setty, B.A.; O'Brien, S.H.; Kerlin, B.A. Pediatric venous thromboembolism in the United States: A tertiary care complication of chronic diseases. Pediatr. Blood Cancer 2012, 59, 258–264. [Google Scholar] [CrossRef] [Green Version]
- Kerlin, B.A.; Smoyer, W.E.; Tsai, J.; Boulet, S.L. Healthcare burden of venous thromboembolism in childhood chronic renal diseases. Pediatr. Nephrol. 2015, 30, 829–837. [Google Scholar] [CrossRef] [Green Version]
- Latin American Pediatric Nephrology Association; Latin American Pediatric Renal Transplant Cooperative Study. Latin American Registry of Pediatric Renal Transplantation 2004–2008. Pediatr. Transplant. 2010, 14, 701–708. [Google Scholar] [CrossRef] [PubMed]
- Haricharan, R.N.; Aprahamian, C.J.; Morgan, T.L.; Harmon, C.M.; Barnhart, D.C. Intermediate-term patency of upper arm arteriovenous fistulae for hemodialysis access in children. J. Pediatr. Surg. 2008, 43, 147–151. [Google Scholar] [CrossRef] [PubMed]
- Suri, D.; Ahluwalia, J.; Saxena, A.K.; Sodhim, K.S.; Singh, P.; Mittal, B.R.; Das, R.; Rawat, A.; Singh, S. Thromboembolic complications in childhood nephrotic syndrome: A clinical profile. Clin. Exp. Nephrol. 2014, 18, 803–813. [Google Scholar] [CrossRef] [PubMed]
- Zhang, L.J.; Zhang, Z.; Li, S.J.; Meinel, F.G.; Nance, J.W.; Zhou, C.S., Jr.; Zhao, Y.E.; Schoepf, U.J.; Lu, G.M. Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: Prospective evaluation of prevalence and risk factors with CT. Radiology 2014, 273, 897–906. [Google Scholar] [CrossRef]
- Kerlin, B.A.; Blatt, N.B.; Fuh, B.; Zhao, S.; Lehman, A.; Blanchong, C.; Mahan, J.D.; Smoyer, W.E. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: A Midwest Pediatric Nephrology Consortium (MWPNC) study. J. Pediatr. 2009, 155, 105–110.e1. [Google Scholar] [CrossRef] [Green Version]
- Hoyer, P.F.; Gonda, S.; Barthels, M.; Krohn, H.P.; Brodehl, J. Thromboembolic complications in children with nephrotic syndrome. Risk and incidence. Acta Paediatr. Scand. 1986, 75, 804–814. [Google Scholar] [CrossRef] [PubMed]
- Stârcea, M.; Gavrilovici, C.; Munteanu, M.; Miron, I. Focal segmental glomerulosclerosis in children complicated by posterior reversible encephalopathy syndrome. J. Int. Med. Res. 2018, 46, 1172–1177. [Google Scholar] [CrossRef]
- Wu, T.; Tang, L.V.; Hu, Y. Venous Thromboembolism in Kidney Diseases and Genetic Predisposition. Kidney Dis. 2022, 8, 181–189. [Google Scholar] [CrossRef] [PubMed]
- Warady, B.A.; Hébert, D.; Sullivan, E.K.; Alexander, S.R.; Tejani, A. Renal transplantation, chronic dialysis, and chronic renal failure in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr. Nephrol. 1997, 11, 49–64. [Google Scholar] [CrossRef] [PubMed]
- Singh, A.; Stablein, D.; Tejani, A. Risk factors for vascular thrombosis in pediatric renal transplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1997, 63, 1263–1270. [Google Scholar] [CrossRef] [PubMed]
- Smith, J.M.; Stablein, D.; Singh, A.; Harmon, W.; McDonald, R.A. Decreased risk of renal allograft thrombosis associated with interleukin-2 receptor antagonists: A report of the NAPRTCS. Am. J. Transplant. 2006, 6, 585–593. [Google Scholar] [CrossRef] [PubMed]
Autors | Study Type | Sample Size and Age | Aims | Main Results |
---|---|---|---|---|
Hennelly KE, Baskin MN, Monuteuax MC, et al., 2016 | Single-center retrospective study | 561 children < 22 years of age | To evaluate the children risk for PE, using adult Wells criteria and Pulmonary Embolism Rule-out Criteria (PERC) | The risk of pulmonary VTE is low among children not receiving estrogen therapy and without tachycardia and hypoxia. Application of the PERC rule and Wells criteria should be used cautiously in the pediatric population. |
Biss TT, Brandão LR, Kahr WH et al., 2009 | retrospective cohort study | 50 children with PE | To evaluated D-dimer value and Wells probability score for PE in children | The Wells clinical probability score and D-dimer estimation may lack utility in the determination of pre-test probability of PE in children. |
Van Ommen CH, Heijboer H, Büller HR et al., 2001 | prospective 2-year registry of VTE in children | 99 children ≤ 18 years old | To study the incidence, diagnostic, and complications of pediatric VTE | VTE is mostly diagnosed in hospitalized children, especially sick newborns with central venous catheters and older children with a combination of risk factors. |
Setty BA, O’Brien SH, Kerlin BA., 2012 | The Kids’ Inpatient Database 2006 | 4500 children ≤ 18 years old | To evaluated the incidence of VTE in tertiary care settings | Pediatric VTE is most commonly seen in tertiary care. Adolescents are at greatest risk to develop in-hospital VTE. |
Suri D, Ahluwalia J, Saxena AK et al., 2013 | retrospective study | 34 children | To evaluated the incidence of venous and arterial thrombosis in children with nephrotic syndrome | Venous and arterial thrombosis occur in children with nephrotic syndrome, with subtle clinical features. Neuroimaging and angiographic techniques confirm diagnosis, and early aggressive heparin therapy is necessary for a favorable outcome. |
Zhang LJ, Zhang Z, Li SJ et al., 2014 | prospective study | 512 patients in the study cohort, 80 children | To determine the prevalence PE and renal vein thrombosis in patients with NS | PE pulmonary embolism and RVT renal vein thrombosis are common in patients with NS, occurring in 19% of children and 38% of adults. PE pulmonary embolism is more common than RVT renal vein thrombosis |
Kerlin BA, Blatt NB, Fuh B et al., 2009 | comprehensive chart review | 326 children | To identify the risk factors of VTE in children with NS | Children with NS have risk for VTE, particularly those who are age 12 years or older, have severe proteinuria, or have a previous history of TE. |
Hoyer PF, Gonda S, Barthels M et al., 1986 | prospective study | 16 children | To evaluated the incidence of VTE in children with steroid responsive minimal change nephrotic syndrome | The incidence of thromboembolic complications in children with severe nephrotic syndrome is as high as reported for adults. |
Singh A, Stablein D, Tejani A, 1997 | The Report of the North American Pediatric Renal Transplant Cooperative Study database | 4394 transplanted children | To identify the risk factors for VTE in transplanted children | Living donor transplant with a history of prior transplantation had a significantly higher rate of thrombosis as compared with those who received a primary transplant. Cold ischemia time greater than 24 h in the patient who received cadaver donor kidney increased the risk for thrombosis. The use of antibody induction therapy, donors greater than 5 years of age, and increasing recipient age were factors that decreased the risk for thrombosis. |
Smith JM, Stablein D, Singh A et al., 2006 | The North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) database | 8990 transplanted children | To identify the risk factors for VTE in transplanted children | The use of IL-2 receptor antibodies as induction therapy is associated with a significantly decreased risk of graft failure due to thrombosis. |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lazaruc, T.I.; Bodescu Amancei Ionescu, L.; Lupu, V.V.; Muntean, C.; Bogos, R.A.; Ivanov, A.; Scurtu, G.; Starcea, I.M.; Miron, I.C.; Mocanu, M.A. Thrombosis in Chronic Kidney Disease in Children. Diagnostics 2022, 12, 2931. https://doi.org/10.3390/diagnostics12122931
Lazaruc TI, Bodescu Amancei Ionescu L, Lupu VV, Muntean C, Bogos RA, Ivanov A, Scurtu G, Starcea IM, Miron IC, Mocanu MA. Thrombosis in Chronic Kidney Disease in Children. Diagnostics. 2022; 12(12):2931. https://doi.org/10.3390/diagnostics12122931
Chicago/Turabian StyleLazaruc, Tudor Ilie, Lavinia Bodescu Amancei Ionescu, Vasile Valeriu Lupu, Carmen Muntean (Duicu), Roxana Alexandra Bogos, Anca Ivanov, Georgiana Scurtu, Iuliana Magdalena Starcea, Ingrith Crenguta Miron, and Maria Adriana Mocanu. 2022. "Thrombosis in Chronic Kidney Disease in Children" Diagnostics 12, no. 12: 2931. https://doi.org/10.3390/diagnostics12122931